Distinct Neural Sites of GLP-1R Expression Mediate Physiological versus Pharmacological Control of Incretin Action.
Cell Rep · 2019
Last updated 2026-05-28A study in mice found that removing GLP-1 receptors from certain brain cells did not affect basic functions like eating, digestion, or blood sugar control. However, the benefits of GLP-1 drugs on blood sugar and weight loss were reduced when these receptors were missing in a specific group of brain cells. The research suggests these cells play a key role in how the body naturally regulates digestion and blood sugar.
AI summary of the abstract below.
| Journal | Cell Rep, 2019 |
|---|---|
| Citations | 91 |
| Relative citation ratio | 3.88 |
| NIH percentile | 89 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity |
Abstract
Glucagon-like peptide 1 (GLP-1) receptors are widely distributed throughout the nervous system, enabling physiological and pharmacological control of glucose and energy homeostasis. Here we elucidated the importance of Glp1r expression within cellular domains targeted by expression of Wnt1-Cre2 or Phox2b-Cre. Widespread loss of neural Glp1r in Glp1r mice had no effect on basal food intake, gastric emptying, and glucose homeostasis. However, the glucoregulatory actions of GLP-1R agonists, but not gut-selective DPP-4 inhibition, were preserved in Glp1r mice. Unexpectedly, selective reduction of Glp1r expression within neurons targeted by Phox2b-Cre impaired glucose homeostasis and gastric emptying and attenuated the extent of weight loss achieved with sustained GLP-1R agonism. Collectively, these studies identify discrete neural domains of Glp1r expression mediating GLP-1-regulated control of metabolism and the gut-brain axis and reveal the unexpected importance of neuronal Phox2b cells expressing GLP-1R for physiological regulation of gastric emptying, islet hormone responses, and glucose homeostasis.
Verbatim abstract via PubMed 31189118 ↗